Related references
Note: Only part of the references are listed.Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update
Carolyn Owen et al.
LEUKEMIA RESEARCH (2023)
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways
Louis Lacombe et al.
CANCER LETTERS (2023)
Chronic lymphocytic leukemia treatment algorithm 2022
Paul J. Hampel et al.
BLOOD CANCER JOURNAL (2022)
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Binyamin A. Knisbacher et al.
NATURE GENETICS (2022)
Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemia
Paul J. Hampel et al.
LEUKEMIA & LYMPHOMA (2021)
ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia
Jingyu Chen et al.
BLOOD (2021)
Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trial
David E. Spaner et al.
CANCER MEDICINE (2021)
Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression
Eric P. Allain et al.
BRITISH JOURNAL OF CANCER (2020)
UGT2B17 modifies drug response in chronic lymphocytic leukaemia
Eric P. Allain et al.
BRITISH JOURNAL OF CANCER (2020)
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
Xiaoya Yun et al.
BIOMARKER RESEARCH (2020)
Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody
Jean-Philippe Emond et al.
DRUG METABOLISM AND DISPOSITION (2019)
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
Uku Raudvere et al.
NUCLEIC ACIDS RESEARCH (2019)
Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia
Eric P. Allain et al.
FRONTIERS IN ONCOLOGY (2019)
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients
Eric P. Allain et al.
ANNALS OF HEMATOLOGY (2018)
Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia
Nisar A. Amin et al.
CLINICAL CANCER RESEARCH (2017)
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia
Matthew D. Blunt et al.
CLINICAL CANCER RESEARCH (2017)
Cross-Talk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism
Yannick Audet-Delage et al.
MOLECULAR PHARMACOLOGY (2017)
Endogenous Protein Interactome of Human UDP-Glucuronosyltransferases Exposed by Untargeted Proteomics
Michele Rouleau et al.
FRONTIERS IN PHARMACOLOGY (2017)
Protocol for adhesion and immunostaining of lymphocytes and other non-adherent cells in culture
Matthew Tsang et al.
BIOTECHNIQUES (2017)
UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
Sujata Bhoi et al.
HAEMATOLOGICA (2016)
UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
Sujata Bhoi et al.
HAEMATOLOGICA (2016)
Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia
Garima Kushwaha et al.
HUMAN GENOMICS (2016)
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Ta-Ming Liu et al.
BLOOD (2015)
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
Rainer Claus et al.
BLOOD (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Dual Roles for Splice Variants of the Glucuronidation Pathway as Regulators of Cellular Metabolism
Melanie Rouleau et al.
MOLECULAR PHARMACOLOGY (2014)
Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia
Michaela Gruber et al.
BLOOD (2013)
LCK Is an Important Mediator of B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia Cells
Fatima Talab et al.
MOLECULAR CANCER RESEARCH (2013)
Quantitative DNA Methylation Analysis Identifies a Single CpG Dinucleotide Important for ZAP-70 Expression and Predictive of Prognosis in Chronic Lymphocytic Leukemia
Rainer Claus et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
International Cancer Genome Consortium Data Portal-a one-stop shop for cancer genomics data
Junjun Zhang et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2011)
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
Albert Gutierrez et al.
BLOOD (2010)
Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia
M. Shehata et al.
LEUKEMIA (2010)
High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort
M. D. Seftel et al.
LEUKEMIA RESEARCH (2009)
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase
Alexander Kohlmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia
Liguang Chen et al.
BLOOD (2008)
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status
C. Ian Mockridge et al.
BLOOD (2007)
ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells
Stefania Gobessi et al.
BLOOD (2007)
Functional protein-protein interaction of drug metabolizing enzymes
Y Ishii et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia
LG Chen et al.
BLOOD (2002)
Share Paper
